Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target

Abstract

MPO may be a key mediator of myeloid inflammation and tissue damage in EAE. Therefore, MPO could represent a promising therapeutic target, as well as an imaging biomarker, for demyelinating diseases and potentially for other diseases in which MPO is implicated.